LALCA 2012 Abstracts Journal of Thoracic Oncology

Slides:

Advertisements

Similar presentations

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Advertisements

PUBLISH ONLY Journal of Thoracic Oncology

European Urology Focus

Lungs on Fire Journal of Thoracic Oncology

SC17.02 Lung Cancer in China: Challenges and Perspectives

ALK FISH and IHC: You Cannot Have One without the Other

Waleed Brinjikji, MD, Jennifer M. Boland Froemming, MD, William P

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Pneumoperitoneum for the management of pleural air space problems associated with major pulmonary resections Tiziano De Giacomo, MD, Erino A Rendina,

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K

NA Journal of Thoracic Oncology

Electronic Updates for JTO Readers

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection* T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.

Pleural mechanics and the pathophysiology of air leaks

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Turning Gray: The Natural History of Lung Cancer Over Time

Frank Detterbeck, MD Journal of Thoracic Oncology

How should we treat air leaks?

A Severe Photosensitivity Dermatitis Caused by Crizotinib

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening.

Multiple Pulmonary Chondroid Hamartoma

ORAL SESSIONS Journal of Thoracic Oncology

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Tamas F. Molnar, Cengiz Gebitekin, Akif Turna

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.

“The Best-Laid Plans … Often go Awry …”

PUBLISH ONLY Journal of Thoracic Oncology

In This Issue Journal of Thoracic Oncology

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Imaging Requirements in the Practice of Pulmonary Metastasectomy

Self-Reported Cardiovascular Disease and the Risk of Lung Cancer, the HUNT Study Peter Hatlen, PhD, MD, Arnulf Langhammer, MD, PhD, Sven Magnus Carlsen,

Onkar V. Khullar, MD, Yuan Liu, PhD, Theresa Gillespie, PhD, Kristin A

Heidi B. Rolke, Frode Gallefoss Journal of Thoracic Oncology

Usefulness of spirometry in air leak evaluation during laparoscopic surgery in an obese patient with laryngeal mask airway Supreme™ M Carron, U Freo,

Sutureless pneumostasis using bioabsorbable mesh and glue during major lung resection for cancer: Who are the best candidates? Kazuhiro Ueda, MD, Toshiki.

P Accuracy of Combined Semantic and Computational CT Features in Predicting Non-Small Cell Lung Cancer Subtype Usman Bashir, Andrea Bille, Levon.

Mitotic Inhibitors Journal of Thoracic Oncology

P3-252: Limited surgery for elderly patients with non-small cell lung cancer who have high risk for lobectomy: Comparison of the short- and the long-term.

P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma Gustavo A. Lyons, Silvia Quadrelli,

Mirror Mirror on the Wall, Who Is the Fairest of Them All

Surgical Treatment of Recurrent Thymomas

ES Lung Cancer Surgery for High Risk Patients

Extending Surgery for Pulmonary Metastasectomy: What Are the Limits?

MTP13-01: Indications and limitations of bronchoscopy

Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma Akihiro Yasumitsu, MD, Chiharu Tabata, MD, PhD, Rie.

Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011) Ellen.

Predicting postoperative morbidity in adult elective surgical patients using the Surgical Outcome Risk Tool (SORT) D.J.N. Wong, C.M. Oliver, S.R. Moonesinghe

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

In This Issue Journal of Thoracic Oncology

Extended Resections for Thymic Malignancies

MTP19-01: T4 N0/N1 nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43% provided a.

International Thymic Malignancies Interest Group: A Way Forward

European Lung Cancer Conference (ELCC) 2016 Organisation

Recurrent Primary Synovial Sarcoma of the Chest Wall

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Metastatic Lung Cancer to the Pancreas

The Effects of Increased Provision of Thoracic Surgical Specialists on the Variation in Lung Cancer Resection Rate in England Kelvin K.W. Lau, DPhil,

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

IASLC 6th Latin American Conference on Lung Cancer

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

David Garfield, MD Journal of Thoracic Oncology

Popcorn in the Lung Journal of Thoracic Oncology

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

LALCA 2012 Abstracts Journal of Thoracic Oncology Journal of Thoracic Oncology Volume 7, Issue 7, Pages S101-S159 (July 2012) DOI: 10.1097/JTO.0b013e318262df76 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Patients with lung cancer had a significantly higher hyaluronan levels in sputum than that in the COPD and healthy controls (Log10 scale; p<0.001) B/C – ROC curves for sputum levels of hyaluronan. B- The cut off level of hyaluronan that result in the highest diagnostic accuracy was >31.44ng/mg. The cut-off point of hyaluronan discriminated between healthy controls and lung cancer patients, with 100% specificity and 51% sensitivity. The diagnostic accuracy was 82%. C- The cut-off point of hyaluronan that discriminated COPD and lung cancer patients, with 100% specificity and 33% sensitivity was >48.3ng/mg. The diagnostic accuracy was 69%. Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10. 1097/JTO Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig. 1(a) Resected specimen of lobectomy with 4 ribs Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig. 1(b) Chest wall reconstruction with Prolene mesh Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig. 1 Active air leak. The upper plot (yellow curve), showing air flows, clearly demonstrates an air leak; the lower plot, separately showing the expiratory pressure (”pe“, blue curve) and the inspiratory pressure (”pi“, azure curve), demonstrates an increasing pleural pressures span. Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig. 2 Late air leak: a progressive pressure curves divergency anticipates the air leak appearance. In the lower plots we can observe an initial interspace between “pe“ (blue curve) and “pi” (azure curve), then a pressure plateau, and finally a progressive curve divergency since the 2nd post-operative hour. a: the greenish-blue line illustrates the progressive increase of differential pressure (Δp=pe-pi) approximately from the 2nd p.o. day.b: the yellow line shows air flows, revealing an air leakage reappearance, anticipated by the differential pressure increasing. Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig. 3 a-b Pleural space effect: high differential pleural pressure without a significant air flow. In both illustrations, referring to a surgical pleurodesis, the lower plots separately show the expiratory (“pe”, blue curve) and inspiratory pressures (“pi”, azure curve), with a wide interspace. In “a”, the upper plot (greenish-blue line) summarizes a high differential pleural pressure (Δp=pe-pi). In “b”, the upper plot (yellow line) describes a sporadic, minimal air flow. Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10. 1097/JTO Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10. 1097/JTO Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10. 1097/JTO Journal of Thoracic Oncology 2012 7, S101-S159DOI: (10.1097/JTO.0b013e318262df76) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions